Artelo Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARTL and other ETFs, options, and stocks.About ARTL
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal.
CEOGregory D. Gorgas
CEOGregory D. Gorgas
Employees6
Employees6
HeadquartersSolana Beach, California
HeadquartersSolana Beach, California
Founded2011
Founded2011
Employees6
Employees6
ARTL Key Statistics
Market cap4.00M
Market cap4.00M
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume2.61M
Average volume2.61M
High today$2.08
High today$2.08
Low today$1.85
Low today$1.85
Open price$2.03
Open price$2.03
Volume308.51K
Volume308.51K
52 Week high$28.60
52 Week high$28.60
52 Week low$1.52
52 Week low$1.52
Stock Snapshot
Artelo Biosciences(ARTL) stock is priced at $1.94, giving the company a market capitalization of 4M. It carries a P/E multiple of -0.09.
On 2025-12-14, Artelo Biosciences(ARTL) stock traded between a low of $1.85 and a high of $2.08. Shares are currently priced at $1.94, which is +4.7% above the low and -6.7% below the high.
The Artelo Biosciences(ARTL)'s current trading volume is 308.51K, compared to an average daily volume of 2.61M.
During the past year, Artelo Biosciences(ARTL) stock moved between $1.52 at its lowest and $28.60 at its peak.
During the past year, Artelo Biosciences(ARTL) stock moved between $1.52 at its lowest and $28.60 at its peak.
People also own
Based on the portfolios of people who own ARTL. This list is generated using Robinhood data, and it’s not a recommendation.